MAPT and Alzheimer disease: At 3 weeks after AD p-Tau injection, we found low-intensity AT8 staining, and at 6 weeks we found high-intensity AT8 staining, in the ipsilateral hippocampus, but only low-intensity AT8 staining at these two time points in the contralateral hippocampus (Fig. 2a).